Register for this event

*Repeated Session

All sessions are live-hosted, screen-to-screen 1.5 hour Continuing Education Sessions (CES) with PRI Trainers. All sessions will be presented via Zoom. PRI is unable to award hours for sessions previously attended.

Please note that participants are responsible for ensuring online PRI sessions and the number of hours earned fulfill your system’s requirements. Credentialing requirements for online sessions stipulate all participants must (1) individually register, and (2) log into the online session on their own device to received credit/hours for attending. Learners who participate in an online session via shared login will not receive a certificate. Learners are also required to attend sessions in full for credit hours to be awarded.  Participants will receive a survey email after the session and will receive a certificate once the survey has been submitted. The link to the surveys are also available on the instructor site under “My Trainings.” Note, participants must attend the entire session.

PRI supports low risk driving choices. Therefore, we will remove anyone who is driving on a Zoom call hosted by our team. So as to not further distract, we will not chat or verbally ask questions first. You’ll be able to join a different Zoom session, from a stationary place, at a later date.

Description:

Substance use disorder has been described as a chronic, relapsing medical condition characterized by recurring periods of relapse and remission. Relapse risk remains high because long-term high-risk substance use causes lasting neurobiological brain changes that persist beyond detoxification. This session will provide an overview of medications used to treat alcohol and opioid use disorders. Participants will explore how these medications work, why they are considered evidence-based treatment options, and how they can support recovery by reducing cravings, withdrawal symptoms, relapse risk, and overdose risk. The session will also address common myths and concerns about medication use and the role of medication alongside education and counseling.

Goals:

Participants will learn about substance use disorders as a chronic health condition, including the neurological changes that can contribute to relapse risk beyond detoxification, learn about commonly used medications for the treatment of alcohol and opioid use disorders, describe how medications support recovery, and address common myths about medication use and understand the role of medication alongside psychosocial treatments.

Learning Objectives:

At the conclusion of the session, participants will be able to:

• Define substance use disorder.
• Explain how medications assist in recovery from opioid and alcohol use disorders.
• Describe common FDA-approved medications for opioid and alcohol use disorder and their mechanisms.
• Identify how medications for opioid and alcohol use disorders integrate with behavioral interventions.

Dates and Times (EASTERN TIME):

September 18, 2026: 9:00 – 10:30 AM Eastern Time

Time Zone Converter (Zoom also gives you the option to add it to your local calendar):
https://time.is/compare